R&D Clinical research demands agile CROs An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.
News Ergomed aims to go private via £703m Permira takeover UK biopharma services company Ergomed will be taken into private hands with a takeover by a subsidiary of investment group Permira that values the company at around £703 m
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
